Carbohydrate Metabolism in Animals

Overview

Carbohydrate metabolism encompasses the biochemical pathways that convert dietary sugars into usable energy, store excess as glycogen or fat, and generate glucose for tissues that depend on it, such as the brain and red blood cells. In mammals, the primary carbohydrate fuel is glucose, but fructose and galactose are also processed after conversion to glycolytic intermediates. The major pathways include glycolysis, the pentosephosphate pathway, the tricarboxylic acid (TCA) cycle, glycogen synthesis and breakdown, and gluconeogenesis.

Glycolysis

Glycolysis is a tenstep cytosolic pathway that splits one molecule of glucose (a sixcarbon sugar) into two molecules of pyruvate (three carbons each). The process can be divided into an energyinvestment phase (steps 15) and an energypayoff phase (steps 610). Net, the pathway yields:

• 2 ATP (produced by substratelevel phosphorylation)
• 2 NADH (which can be reoxidized in the mitochondria)
• 2 pyruvate molecules, which may become lactate (anaerobic) or enter the mitochondria for further oxidation (aerobic).

The key regulatory enzymes are hexokinase/glucokinase, phosphofructokinase1 (PFK1), and pyruvate kinase. Their activities respond to the cells energy status (ATP/ADP, AMP), citrate levels, and hormonal signals such as insulin and glucagon.

Linkage Pathways

PentosePhosphate Pathway (PPP)

The PPP runs parallel to glycolysis, producing NADPH for biosynthetic reactions and ribose5phosphate for nucleotide synthesis. Its oxidative branch generates two NADPH per glucose, while the nonoxidative branch interconverts sugars of varying chain lengths, linking back to glycolysis.

Glycogen Metabolism

Glycogen is the primary storage form of glucose in liver and skeletal muscle. Glycogenesis (synthesis) uses UDPglucose and the enzyme glycogen synthase, regulated by insulinstimulated dephosphorylation. Glycogenolysis (breakdown) is catalyzed by glycogen phosphorylase, which is activated by glucagon, epinephrine, and low ATP/energy charge.

Tricarboxylic Acid (TCA) Cycle

In the presence of oxygen, pyruvate is transported into mitochondria, where pyruvate dehydrogenase converts it to acetylCoA. AcetylCoA combines with oxaloacetate to form citrate, initiating the TCA cycle. Each turn of the cycle yields:

• 3 NADH
• 1 FADH
• 1 GTP (equivalent to ATP)
• 2 CO (released as waste)

The highenergy electrons carried by NADH and FADH are transferred to the electron transport chain, driving oxidative phosphorylation and producing the bulk of cellular ATP.

Gluconeogenesis

Gluconeogenesis synthesizes glucose from noncarbohydrate precursors (lactate, glycerol, glucogenic amino acids) mainly in liver and, to a lesser extent, kidney cortex. It mirrors glycolysis but uses distinct enzymes at three irreversible steps:

1. Pyruvate carboxylase (mitochondrial) converts pyruvate to oxaloacetate.
2. Phosphoenolpyruvate carboxykinase (PEPCK) oxaloacetate to phosphoenolpyruvate.
3. Fructose1,6bisphosphatase converts fructose1,6bisphosphate to fructose6phosphate.
4. Glucose6phosphatase dephosphorylates glucose6phosphate to free glucose.

Hormonal regulation is opposite to glycolysis: glucagon and cortisol stimulate, while insulin inhibits gluconeogenesis. This balance maintains euglycemia during fasting or prolonged exercise.

Regulation of Carbohydrate Metabolism

Metabolic pathways are coordinated through allosteric effectors, covalent modification, transcriptional control, and hormonal signaling. Key points include:

The concentration of fructose2,6bisphosphate, a potent PFK1 activator and FBPase1 inhibitor, is a central integrator of hormonal signals in the liver.

Clinical Relevance

Dysregulation of carbohydrate metabolism underlies many metabolic diseases:

• Diabetes mellitus: Insufficient insulin action leads to hyperglycemia, increased gluconeogenesis, and impaired glycogen synthesis.
• Glycogen storage diseases (GSD): Genetic defects in enzymes such as glycogen synthase, phosphorylase, or debranching enzyme cause abnormal glycogen accumulation and muscle or liver dysfunction.
• Lactic acidosis: Excessive anaerobic glycolysis produces high lactate, seen in shock, severe hypoxia, or mitochondrial disorders.
• Hereditary fructose intolerance: Aldolase B deficiency prevents metabolism of fructose, leading to hypoglycemia and hepatic injury after fructose ingestion.

Therapeutic strategies target key control points: metformin suppresses hepatic gluconeogenesis, while insulin therapy enhances glucose uptake and glycogen synthesis. Dietary management (e.g., low fructose or lowgalactose diets) is crucial for specific inborn errors.